animated
Ongoing Projects > IRE Registry

 

REGISTRY OF IRREVERSIBLE ELECTROPORATION FOR THE ABLATION OF

PROSTATE CANCER WITH USE OF NANOKNIFE DEVICE

 
A Multi-Center, International Registry to evaluate the treatment of Prostate Cancer in

terms of Recurrence, Functional outcomes and Safety.

 

 


Primary study objective:

The aim of this registry is to assess the recurrence of prostate cancer at 1 and 5 years, as well as the
change in functional outcomes (e.g. incontinence or erectile function) from baseline.  


Secondary study objectives:

To establish which indications lead to treatment with IRE Nanoknife® setting and safety assessment
measured by number of complications and adverse events.





 

Observational data from patients who meet the inclusion criteria below will be recorded:

- Is diagnosed with histologically confirmed prostate cancer

- Is scheduled for IRE Nanoknife®

- Has signed informed consent form

 
Click here to download the protocol

Click here to download the patient information

Click here to download the short-IIEF Questionnaire

Click here to download the I-PSS Questionniare

Office   Contact us   Disclaimer   Conditions